The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001034853.2(RPGR):c.2057T>A (p.Met686Lys)

CA10385310

1276872 (ClinVar)

Gene: RPGR (HGNC:6103)
Condition: RPGR-related retinopathy (MONDO:0100437)
Inheritance Mode: X-linked inheritance
UUID: 61b91eef-87da-47a0-bc00-83a05fe472d0
Approved on: 2025-08-04
Published on: 2025-08-04

HGVS expressions

NM_001034853.2:c.2057T>A
NM_001034853.2(RPGR):c.2057T>A (p.Met686Lys)
NC_000023.11:g.38286942A>T
CM000685.2:g.38286942A>T
NC_000023.10:g.38146195A>T
CM000685.1:g.38146195A>T
NC_000023.9:g.38031139A>T
NG_009553.1:g.45594T>A
ENST00000494707.6:c.953+923T>A
ENST00000642170.1:n.1826+4017T>A
ENST00000642395.2:c.1905+152T>A
ENST00000642739.1:c.1572+4017T>A
ENST00000644238.1:c.1386+4017T>A
ENST00000644337.1:c.1719+152T>A
ENST00000645032.1:c.2057T>A
ENST00000645124.1:c.*101+152T>A
ENST00000646020.1:c.*594+152T>A
ENST00000318842.11:c.1905+152T>A
ENST00000339363.7:c.2520+152T>A
ENST00000378505.6:c.2057T>A
ENST00000465127.1:c.172-379179A>T
ENST00000474584.5:c.*37+4017T>A
ENST00000482855.5:c.1905+152T>A
ENST00000494707.5:c.139+4017T>A
NM_000328.2:c.1905+152T>A
NM_001034853.1:c.2057T>A
NM_001367245.1:c.1902+152T>A
NM_001367246.1:c.1719+152T>A
NM_001367247.1:c.1572+4017T>A
NM_001367248.1:c.1602+4017T>A
NM_001367249.1:c.1569+4017T>A
NM_001367250.1:c.1569+4017T>A
NM_001367251.1:c.1386+4017T>A
NR_159803.1:n.2263+152T>A
NR_159804.1:n.1648+4017T>A
NR_159805.1:n.1714+4017T>A
NR_159806.1:n.1866+152T>A
NR_159807.1:n.1622+4017T>A
NR_159808.1:n.1826+4017T>A
NM_000328.3:c.1905+152T>A
More

Benign

Met criteria codes 2
BP4_Strong BA1
Not Met criteria codes 2
BS2 PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
X-linked Inherited Retinal Disease VCEP
NM_001034853.2(RPGR):c.2057T>A (p.Met686Lys) is a missense variant predicted to cause substitution of methionine by lysine at amino acid 686. This variant is present in gnomAD v.4.1.0 at a frequency of 0.002245 among hemizygous individuals, with 874 variant alleles / 389,312 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). This variant has been observed in at least 3 affected male individuals with features consistent with retinopathy, but was not considered to be the causal variant PMID: 33846575, 24938718). The computational predictor REVEL gives a score of 0.014, which is below the ClinGen X-linked IRD VCEP threshold of < 0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.2 and does not strongly predict an impact on splicing (BP4_Strong). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP4_Strong. (date of approval 05/16/2025).
Met criteria codes
BP4_Strong
The computational predictor REVEL gives a score of 0.014, which is below the ClinGen X-linked IRD VCEP threshold of < 0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.2 and does not strongly predict an impact on splicing (BP4_Strong).
BA1
This variant is present in gnomAD v.4.1.0 at a frequency of 0.002245 among hemizygous individuals, with 874 variant alleles / 389,312 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1).
Not Met criteria codes
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
This variant has been observed in at least 3 affected male individuals with features consistent with retinopathy, but was not considered to be the causal variant PMID: 33846575, 24938718).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.